MICSI · May 2026
NYU Entrepreneur profile highlighting MICSI’s AI-powered medical imaging work and current positioning.
Company research
Public company, workplace, funding, and market signals
Overview
MICSI (Microstructure Imaging Inc.) builds FDA-cleared software that upgrades existing MRI and PET scanners by denoising images, improving resolution, and reducing scan time. The company’s public positioning centers on making advanced imaging more accessible, more cost-effective, and more diagnostically powerful.
Primary product
MICSI-RMT
Founded
2018
Headquarters
New York City, New York, United States
Team size
1-10 employees
Industry
Technology, Information and Internet
Sub-industry
Medical imaging software
Offices
New York City, NY (HQ)
San Francisco, CA
New York, NY, United States
Business model
B2B software
enterprise clinical software
Funding
Stage
Seed
Total raised
$11.9M
Latest round
Grant (prize money) · Jan 2025
People & investors
Leadership
Chief Executive Officer
Chief Technology Officer
Medical Advisor
Scientific Advisor
Scientific Advisor
Work & culture
Public materials suggest a small, research-driven, clinically oriented startup focused on translating academic MRI physics into FDA-cleared products, with an emphasis on publication-backed rigor and compliance/trust.
Product & market
Pricing
Not publicly disclosed; appears to be demo-led enterprise software sales.
Differentiators
- —FDA 510(k)-cleared MRI image enhancement
- —MP-PCA denoising without external training data
- —claims to preserve anatomy and avoid hallucinations
- —works on existing scanners without hardware upgrades
- —reduces scan time / requires fewer images
- —DICOM integration into medical workflows
- —applies the same physics-based approach to PET
Technology
MP-PCA
random matrix theory
self-supervised denoising
Bayesian parameter estimation
weighted linear least squares
DICOM routing
diffusion MRI processing
functional MRI processing
PET imaging
Customers
radiology departments
imaging centers
hospitals
PET imaging programs
neuroimaging teams
Competitors
Subtle Medical
AIdoc
ScreenPoint
SyntheticMR
Scale & contact
Estimated revenue
≈$0.26M/year (third-party estimate)
Estimated monthly visits
1.4K
Traffic estimate as of Jul 2026
Latest news
MICSI · Mar 2025
Company update on a reproducibility study showing denoising can reduce variability and sample-size requirements in diffusion MRI.
MICSI · Oct 2024
MICSI announced it was a semifinalist in two AuntMinnie radiology award categories.
MICSI · Sep 2024
Conference/news update that MICSI exhibited at RSNA 2024.
MICSI · Jul 2024
MICSI announced FDA 510(k) clearance for MICSI-RMT, its MRI image enhancement software.
Jobs and careers at MICSI
0 jobs at MICSI
No open positions
Check back later for new openings